We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,703
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Automatic Data Processing
ADP
$107B
| $205M | 0.24% |
850,206
-6,312
| -0.7% | -$1.54M |
|
77
Intuitive Surgical
ISRG
$130B
| $198M | 0.23% |
677,453
+3,963
| +0.6% | +$1.24M |
|
78
Mondelez International
MDLZ
$79.2B
| $196M | 0.23% |
2,820,804
+51,293
| +2% | +$3.7M |
|
|
MRSH
79
Marsh
MRSH
$92B
| $195M | 0.23% |
1,026,985
-7,044
| -0.7% | -$1.35M |
|
80
Boeing
BA
$187B
| $195M | 0.23% |
1,016,258
+17,954
| +2% | +$3.93M |
|
81
RTX Corp
RTX
$294B
| $191M | 0.22% |
2,651,663
+33,358
| +1% | +$2.86M |
|
82
CVS Health
CVS
$133B
| $188M | 0.22% |
2,698,144
-14,322
| -0.5% | -$1.01M |
|
83
Blackrock
BLK
$175B
| $188M | 0.22% |
291,391
-6,989
| -2% | -$4.88M |
|
84
Cigna
CI
$74.5B
| $186M | 0.22% |
650,514
-4,175
| -0.6% | -$1.19M |
|
85
Stryker
SYK
$131B
| $185M | 0.21% |
677,486
-4,145
| -0.6% | -$1.19M |
|
86
Zoetis
ZTS
$31.9B
| $183M | 0.21% |
1,049,671
+22,164
| +2% | +$4.02M |
|
87
American Tower
AMT
$81.7B
| $180M | 0.21% |
1,097,575
-3,958
| -0.4% | -$723K |
|
88
American Express
AXP
$233B
| $179M | 0.21% |
1,197,384
+7,074
| +0.6% | +$1.16M |
|
89
Analog Devices
ADI
$185B
| $173M | 0.2% |
990,562
-10,353
| -1% | -$1.91M |
|
90
Lockheed Martin
LMT
$135B
| $172M | 0.2% |
421,765
+9,553
| +2% | +$4.24M |
|
91
Lam Research
LRCX
$398B
| $172M | 0.2% |
2,739,760
-3,750
| -0.1% | -$246K |
|
|
SCHW
92
Charles Schwab
SCHW
$184B
| $168M | 0.2% |
3,065,857
-17,903
| -0.6% | -$1.08M |
|
93
Progressive
PGR
$122B
| $163M | 0.19% |
1,168,448
-384
| -0% | -$50.5K |
|
94
Vertex Pharmaceuticals
VRTX
$119B
| $161M | 0.19% |
463,751
+425
| +0.1% | +$149K |
|
95
Eaton
ETN
$170B
| $161M | 0.19% |
753,257
+4,525
| +0.6% | +$976K |
|
96
Citigroup
C
$230B
| $156M | 0.18% |
3,795,200
+84,721
| +2% | +$3.72M |
|
97
Boston Scientific
BSX
$71.1B
| $156M | 0.18% |
2,947,652
+24,133
| +0.8% | +$1.27M |
|
98
Chubb
CB
$134B
| $154M | 0.18% |
741,060
-8,731
| -1% | -$1.77M |
|
99
T-Mobile US
TMUS
$190B
| $151M | 0.18% |
1,079,241
-48,887
| -4% | -$6.77M |
|
100
Regeneron Pharmaceuticals
REGN
$78.2B
| $151M | 0.18% |
183,278
-2,795
| -2% | -$2.2M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.